FolioLanternBeta
ONCBeOne Medicines Ltd.

Chan Lee

SVP, General Counsel at BeOne Medicines Ltd., as of Oct 2, 2026Sold $4.6M of stock in the past 12 months: 82% under a disclosed plan and 18% to cover taxes.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
14K
shares sold, past 12 months
16
days with sales
$960K
largest single day, Aug 11, 2026
1
company filed for

Share of stake sold and shares held at BeOne Medicines Ltd. are not shown: the holdings do not reconcile with the filings. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
OctNov 2025: $348K under a disclosed planNovDec 2025: $214K under a disclosed planDecJan 2026: $220K under a disclosed planJanFeb 2026: $580K under a disclosed planFebMar 2026: $102K under a disclosed planMarApr 2026: $103K under a disclosed planAprMay 2026: $103K under a disclosed planMayJun 2026: $503K to cover taxesJunJul 2026: $743K under a disclosed planJul 2026: $338K to cover taxes$1.1MJulAug 2026: $960K under a disclosed planAugSep 2026: $418K under a disclosed planSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
BeOne Medicines Ltd. (ONC)SVP, General CounselJun 20, 2023Oct 2, 2026

Recent filings

The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.